Agilent to Sponsor Global Forensics Congress in Portugal
News Aug 27, 2013
Agilent Technologies Inc. has announced that it will host a series of scientific presentations at the annual meeting of the International Association of Forensic Toxicologists (TIAFT), Sept. 2-6, in Madeira, Portugal.
TIAFT is a prominent international forensics trade association. Its annual congress draws hundreds of forensic and analytical toxicologists from all over the world.
“For over a decade, Agilent has been a proud sponsor of TIAFT’s international meetings and the association’s mission to promote education, training and research in forensic toxicology and related disciplines,” said Tom Gluodenis, Agilent’s global marketing manager of Forensics and Toxicology. “We are pleased to continue our support for this forum highlighting the latest advances in measurement technology.”
Agilent Program Highlights
Tuesday evening keynote address: “Analytical Identification - At the Core of the EU Early Warning System,” presented by Dr. Andrew Cunningham of the European Monitoring Centre for Drugs & Drug Addiction, Lisbon.
Wednesday technical presentation: “Latest Advances in GC/MS, LC/MS, Spectroscopy and Sample-Preparation Technologies for Isometric/Designer Drugs, Drug Metabolite Analysis and Trace Metal Analysis,” presented by Agilent scientists Bernhard Wüest, Juan Aybar, Jaume Morales, Dr. Amparo Villar and Laure Blanc.
Poster presentation: “Ethylglucuronide Determination in Hair as an Indicator of Chronic Alcohol Abuse - A Fully Validated Method in GC-EI-MS/MS,” presented by Dr. Jennifer Pascali, DTOLabs (Agilent authorized partner laboratory), Resana, Italy, and Dr. Franco Tagliaro, Department of Public Health and Community Medicine, Section of Forensic Medicine, University of Verona, Verona, Italy.
Attendees are also invited to visit Agilent’s exhibit (Booth No. 1) to talk with scientists and view the company’s latest advances in sample-preparation technology, chromatography, spectrometry and mobile-measurement solutions for use in forensic toxicology, anti-doping initiatives and related applications.
New Partnership to Provide Bioanalytical and DMPK ServicesNews
Concept Life Sciences, the integrated drug discovery, development and analytical services company, and Alderley Analytical, bioanalytical Contract Research Organisation (CRO), today announced they have signed a partnership agreement to provide high-value bioanalytical and DMPK study services.